A detailed history of Mhr Fund Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mhr Fund Management LLC holds 23,997,103 shares of IOVA stock, worth $265 Million. This represents 28.39% of its overall portfolio holdings.

Number of Shares
23,997,103
Previous 23,997,103 -0.0%
Holding current value
$265 Million
Previous $356 Million 45.88%
% of portfolio
28.39%
Previous 40.86%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$7.59 - $17.47 $30.4 Million - $69.9 Million
4,000,000 Added 20.0%
23,997,103 $356 Million
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $35.5 Million - $70.3 Million
8,000,000 Added 66.68%
19,997,103 $91 Million
Q4 2022

Feb 14, 2023

BUY
$5.62 - $10.0 $67.4 Million - $120 Million
11,997,103 New
11,997,103 $76.7 Million

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Mhr Fund Management LLC Portfolio

Follow Mhr Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mhr Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mhr Fund Management LLC with notifications on news.